Ozenoxacin
C21H21N3O3
363.42
3-Quinolinecarboxylic acid, 1-cyclopropyl-1,4-dihydro-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-;
1-Cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)pyridin-3-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid [245765-41-7]
3-Quinolinecarboxylic acid, 1-cyclopropyl-1,4-dihydro-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-;
1-Cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)pyridin-3-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid [245765-41-7]
BRIEFING
Ozenoxacin. Because there is no existing USP monograph for this drug substance, a new monograph based on validated methods of analysis is proposed. The liquid chromatographic procedures in the Assay and the Organic Impurities test are based on validations performed with the XTerra RP18 brand of column with L1 packing. The typical retention time for ozenoxacin is about 11 min.
Description and solubility information: White to pale-yellow crystalline powder. Soluble in dimethyl sulfoxide (DMSO) and in water (pH 8.5).
(SM1: M. Fadadu)
Case ID—SUB-1959
USP REFERENCE STANDARDS FOR PURCHASE
USP Ozenoxacin RSUSP Ozenoxacin Related Compound A RS
USP Ozenoxacin Related Compound B RS